In Vivo Dose Threshold Effect of Adenovirus-Mediated Factor VIII Gene Therapy in Hemophiliac Mice
Open Access
- 30 September 2000
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 2 (3), 223-232
- https://doi.org/10.1006/mthe.2000.0120
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Gene Transfer by AdenovectorsBlood, 1999
- Adenovirus-Mediated Expression of Human Coagulation Factor IX in the Rhesus Macaque Is Associated With Dose-Limiting ToxicityBlood, 1999
- Adenovirus vectors for gene deliveryCurrent Opinion in Biotechnology, 1999
- Development and application of adenoviral vectors for gene therapy of cancerCancer Gene Therapy, 1999
- An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgeneProceedings of the National Academy of Sciences, 1998
- Sustained Phenotypic Correction of Murine Hemophilia A by In Vivo Gene TherapyBlood, 1998
- In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 DeletedJournal of Virology, 1998
- Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicityNature Genetics, 1998
- Characterization of adenovirus hexons by their epitope compositionArchiv für die gesamte Virusforschung, 1996
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994